SuperworthImmunome shares outstanding IMNM
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 113.3M
- On a year earlier
- +30.2%
- more shares
Immunome had 113.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 30.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 94.8M | +51% |
| FY2024 | 62.8M | +48% |
| FY2023 | 42.5M | +251% |
| FY2022 | 12.1M | +0% |
| FY2021 | 12.1M | +1002% |
| FY2019 | 1.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 113.3M | +30% | |
| Q1 FY26 | 113.1M | +42% | |
| Q4 FY25 | 94.8M | +51% | |
| Q3 FY25 | 88M | +46% | |
| Q2 FY25 | 87M | +45% | |
| Q1 FY25 | 79.4M | +54% | |
| Q4 FY24 | 62.8M | +48% | |
| Q3 FY24 | 60.2M | +393% | |
| Q2 FY24 | 59.9M | +391% | |
| Q1 FY24 | 51.5M | +323% | |
| Q4 FY23 | 42.5M | +251% | |
| Q3 FY23 | 12.2M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Immunome
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.